Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics in vivo
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Conducted to sound scientific principles.

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
TRIS(2-ETHYLHEXYL)BENZENE-1,2,4-TRICARBOXYLATE
Author:
OECD SIDS
Year:
2002
Bibliographic source:
SIDS initial Assessment Report for Siam 14: TRIS(2-ETHYLHEXYL)BENZENE-1,2,4-TRICARBOXYLATE
Reference Type:
publication
Title:
Tissue distribution and excretion of tris(2-ethylhexyl)trimellitate in rats
Author:
Martis L et al
Year:
1987
Bibliographic source:
J. Toxicol. Envir. Hlth 20, 357-366

Materials and methods

GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate
EC Number:
222-020-0
EC Name:
Tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate
Cas Number:
3319-31-1
Molecular formula:
C33H54O6
IUPAC Name:
tris(2-ethylhexyl) benzene-1,2,4-tricarboxylate
Constituent 2
Reference substance name:
Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylate
IUPAC Name:
Tris(2-ethylhexyl)benzene-1,2,4-tricarboxylate

Test animals

Species:
rat

Administration / exposure

Route of administration:
intravenous

Results and discussion

Applicant's summary and conclusion

Conclusions:
TOTM given intravenously accumulated in the liver (72%), lungs and spleen in rats within 24 hours. Biliary excretion, the main elimination route, was slow indicating a potential for accumulation in these target organs.
Executive summary:

The disposition kinetics of tri-(2-ethylhexyl)trimellitate (TOTM), was studied in rats following intravenous administration of [14C-carbonyl]tri-(2-ethylhexyl)trimellitate using an oil in water emulsion as the vehicle. The distribution half-life, elimination half-life, and clearance values estimated from the plasma concentration of radioactivity data obtained following iv administration of 10.5 mg/kg of TOTM (59.9 muCi/kg), were 46.2 min, 5.34 d, and 40.5 ml/kg h, respectively. Following iv dosage of 15.6 mg/kg of TOTM (28.0 muCi/kg), significant accumulation of radioactivity was found in the liver, lungs, and spleen, with liver accounting for 72% of the administered dosage at 24 h. Excretion of TOTM and its biotransformation products was slow, with 21.3% of the administered radioactivity found in the feces and 2.8% in the urine during the 14-d collection period. Biliary excretion seems to be the major route of elimination of TOTM.